Roche at SCOPE 2027

Mar 1–4, 2027 Orlando, FL ~5k attendees Website

Roche brings 4 presentations to SCOPE 2027 in Orlando. Its sessions center on risk-based quality management at portfolio scale and a data-centric, AI-powered quality management system. A distinctive topic is using digitally derived measures to raise the odds of success in Parkinson's disease trials.

Organization	SCOPE 2027 Attendance
Roche Basel, Switzerland
roche.com Large pharma Swiss pharmaceutical and diagnostics company with medicines in oncology, immunology, neuroscience and other areas.	Talk Tue Mar 2 11:05am–11:30am Scaling Enterprise Risk-Based Quality Management: From Study Oversight to Portfolio Impact Quality & Monitoring · with Boehringer Ingelheim Talk Tue Mar 2 12:20pm–12:45pm Neuron23 and Roche: Use of Digitally-Derived Measures to Increase Probability of Parkinson’s Disease Clinical Trial Success Digital Measures & eClinical Technologies · with Neuron23 Talk Tue Mar 2 4:45pm–5:10pm Data Framework for an AI-Powered Digital QMS: From Document-Centric Control to Data-Centric Process Acceleration Quality & Monitoring · with Boehringer Ingelheim Panel Wed Mar 3 3:25pm–3:50pm From Data Noise to Decision: Making RBQM Work at Scale Plenary · with Pfizer, BeOne Medicines Quality, monitoring and safety

Organization

SCOPE 2027 Attendance

Roche

Basel, Switzerland

roche.com

Large pharma

Swiss pharmaceutical and diagnostics company with medicines in oncology, immunology, neuroscience and other areas.

Talk

Tue Mar 2
11:05am–11:30am

Scaling Enterprise Risk-Based Quality Management: From Study Oversight to Portfolio Impact

Quality & Monitoring · with Boehringer Ingelheim

Talk